Table-2.
Pathogen screening of experimental pigs before in vivo trials.
| Groups | No. of pigs tested | Real-time PCR results | ELISA | ||||
|---|---|---|---|---|---|---|---|
|
|
|
||||||
| ASFV | FMDV | PRRSV | CSFV | ASFV IgG | |||
| 1 | Negative control | 3 | negative | negative | negative | negative | negative |
| 2 | Positive control | 6 | negative | negative | negative | negative | negative |
| 3 | Treatment group 1 (NOBF) with direct challenge | 6 | negative | negative | negative | negative | negative |
| 4 | Treatment group 2 (NOBF) with incubated challenge | 6 | negative | negative | negative | negative | negative |
ASFV=African swine fever virus, NOBF=Natural oil blend formulation, FMDV=Foot and mouth disease virus, PRRSV=Porcine reproductive and respiratory syndrome virus, CSFV=Classical swine fever virus